Home Healthcare: Air Liquide Rolls out Its First “Chronic Care ConnectTM” E-Health Solution
September 11 2017 - 11:35AM
Business Wire
Regulatory News:
“Chronic Care Connect™” is a remote monitoring solution in
order to support remotely patients with chronic conditions at home
using digital. Thanks to this technology, patients are monitored on
a daily basis remotely with individualized support provided by Air
Liquide (Paris:AI) nurses via a certified nursing
center.
Depending on the medical monitoring protocol prescribed by the
physician, patients use one or more connected systems (blood
pressure monitor, scale, pulse oximetry, glucose meter or
ventilator, for example). Each device is connected to a digital
tablet that allows patients to access their monitoring. Patient
medical data is sent to and analyzed by the nurses who serve the
Air Liquide center, which exchanges information regularly with
patients and their physicians.
Patients benefit from personalized support, which helps
to improve their quality of life, staying at home. As for
their physicians, they have access to an operational solution that
allows for preventive management of patient condition
evolution. By avoiding hospitalization, the Air Liquide
connected solution for the remote monitoring of patients also meets
the challenges of healthcare costs control.
A study in Germany involving patients with chronic heart failure
who benefit from this kind of monitoring revealed a likelihood
of survival increased by nearly 50% one year out.1
Air Liquide’s connected solution is currently being rolled out
in France and in Spain, currently available for selected
patients suffering from chronic heart failure and
diabetes. In the months ahead, it will also be made
available to patients care with chronic respiratory failure.
François Jackow, member of the Air Liquide group’s
Executive Committee, supervising Healthcare activities, said:
"The rapid adoption of digital technologies, coupled with human
healthcare support, opens up new opportunities to provide
innovative services to patients, physicians, and healthcare
systems. With its first e-health solution, Air Liquide is able to
support patients in their homes and respond to the challenges
facing health authorities."
Air Liquide Healthcare
Air Liquide provides medical gases,
home healthcare services, hygiene products, medical equipment, and
specialty ingredients.
In 2016, it served more than 15 000
hospitals and clinics and more than 1.4 million home
healthcare patients around the world. In 2016, Air
Liquide’s Healthcare business generated revenue of €3,111
million euros with the support of its 15 000 people.
Air Liquide Home Healthcare
Business
Air Liquide, European leader in home
healthcare, provides home healthcare services in compliance
with medical prescription for patients suffering from chronic
diseases such as COPD (Chronic Obstructive Pulmonary Disease),
sleep apnea and diabetes. These home healthcare services are being
developed in addition to hospital care, enabling patients to enjoy
better quality of life and local authorities to reduce costs. Home
healthcare represents 50% of Air Liquide's revenue in Healthcare
in 2016.
The world leader in gases, technologies and services for
Industry and Health, Air Liquide is present in 80 countries with
approximately 65,000 employees and serves more than 3 million
customers and patients. Oxygen, nitrogen and hydrogen are essential
small molecules for life, matter and energy. They embody Air
Liquide’s scientific territory and have been at the core of the
company’s activities since its creation in 1902.
Air Liquide’s ambition is to lead its industry, deliver
long-term performance and contribute to sustainability. The
company’s customer-centric transformation strategy aims at
profitable growth over the long term. It relies on operational
excellence, selective investments, open innovation and a network
organization implemented by the Group worldwide. Through the
commitment and inventiveness of its people, Air Liquide leverages
energy and environment transition, changes in healthcare and
digitization, and delivers greater value to all its
stakeholders.
Air Liquide’s revenue amounted to €18.1 billion in 2016 and its
solutions that protect life and the environment represented more
than 40% of sales. Air Liquide is listed on the Euronext Paris
stock exchange (compartment A) and belongs to the CAC 40, EURO
STOXX 50 and FTSE4Good indexes.
1 Herold R, et al. Telemedical Care and Monitoring for Patients
with Heart Failure has a positive Effect on Survival. Health
Services Research, 2017
https://www.ncbi.nlm.nih.gov/pubmed/28138988
www.airliquide.comFollow us on Twitter
@airliquidegroup
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170911005862/en/
Air LiquideCorporate CommunicationsCaroline
Brugier, +33 (0)1 40 62 50 59Aurélie Wayser-Langevin, +33 (0)1 40
62 56 19orInvestor RelationsParis+33 (0)1 40 62 50
87Radnor+1 (0) 610 263 8277orAir Liquide Healthcare
CommunicationsCoralie Gazzeri, +33(0)1 49 69 45 40
C3 AI (NYSE:AI)
Historical Stock Chart
From Aug 2024 to Sep 2024
C3 AI (NYSE:AI)
Historical Stock Chart
From Sep 2023 to Sep 2024